Open AccessExtended-Spectrum β-Lactamase and Carbapenemase Producing Gram-Negative Bacilli Infections Among Patients in Intensive Care Units of Felegehiwot Referral Hospital: A Prospective Cross-Sectional Study
Author(s) -
Mekonnen Alebel,
Feleke Mekonnen,
Wondemagegn Mulu
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s292246
Subject(s) - medicine , cefotaxime , sputum , ceftazidime , intensive care , microbiology and biotechnology , trimethoprim , intensive care unit , cefuroxime , antibiotics , intensive care medicine , biology , tuberculosis , pseudomonas aeruginosa , genetics , pathology , bacteria
Owing to the specific risk profile of its residents, intensive care units (ICUs) are the best place for selection pressure and the epicenter for resistance development and dissemination. Infections with β-lactamase releasing Gram-negative bacilli (GNB) at ICUs are an emerging global threat. This study dogged the magnitude of extended-spectrum β-lactamase (ESBL) and carbapenemase releasing Gram-negative bacilli infections and associated factors among patients in the ICUs of Felegehiwot Referral Hospital, Ethiopia.